# Boehringer Ingelheim Pharma GmbH & Co. KG - Inspection Records

Source: https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263

> Inspection records and compliance data for Boehringer Ingelheim Pharma GmbH & Co. KG in Ingelheim am Rhein, None. Access full analysis and detailed observations.

---

## Details

- Name: Boehringer Ingelheim Pharma GmbH & Co. KG
- FEI Number: 3002806556
- City: Ingelheim am Rhein
- State: None
- Country Name: Germany
- Address Line 1: Boehringer Ingelheim KG., Binger Str. 173
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2026-05-01](https://www.keypedia.com/records/483/boehringer-ingelheim-pharma-gmbh-co-kg/bd8df4e5-26ea-4b1c-b318-17015aa2448a) — source: FDA, date: May 1, 2026
- [FDA Inspection 1208521 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2021-10-07](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/9d43c9ec-b673-4acd-9149-001abff90db2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 7, 2021
- [FDA Inspection 1053519 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2018-05-04](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/256e5980-df7b-4049-9703-ac50c6fbc5de) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2018
- [FDA Inspection 1053519 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2018-05-04](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/3b1157b7-eb68-4ae7-80b6-a033ffb491eb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2018
- [FDA Inspection 962108 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2016-03-08](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/f1d99f01-f80f-4e2f-9332-40876897d636) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 8, 2016
- [FDA Inspection 921540 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2015-01-23](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/3695817e-3e64-4348-a694-1b0f21566aad) — classification: No Action Indicated (NAI), source: FDA, date: January 23, 2015
- [FDA Inspection 877010 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2014-03-07](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/1205e70b-8f93-47ab-8658-c10db8cbc365) — classification: No Action Indicated (NAI), source: FDA, date: March 7, 2014
- [FDA Inspection 877010 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2014-03-07](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/e4c87b4e-5400-442e-b7d1-c478faafd102) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 7, 2014
- [FDA Inspection 808119 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2012-11-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/952b84e6-8762-4fed-9763-68c3266907f3) — classification: Official Action Indicated (OAI), source: FDA, date: November 12, 2012
- [FDA Inspection 647471 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2010-02-05](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/4fcb7dc7-768b-487e-8d8e-9b7ef19ff784) — classification: No Action Indicated (NAI), source: FDA, date: February 5, 2010
- [FDA Inspection 597254 - Boehringer Ingelheim Pharma GmbH & Co. KG - 2009-06-05](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/2b33381e-09cd-4409-8da9-d87efb4b583c) — classification: No Action Indicated (NAI), source: FDA, date: June 5, 2009

## Related Companies

- [Particle Dynamics LLC](https://www.keypedia.com/companies/particle-dynamics-llc/0fdd4014-06a4-402c-9438-71b62c24f197)
- [Merck Serono SA](https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Union Agener Inc](https://www.keypedia.com/companies/union-agener-inc/df0cd656-2745-4427-bd39-ebb3bec4ea19)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Bio-Technology General (Israel), Ltd.](https://www.keypedia.com/companies/bio-technology-general-israel-ltd/7e4f2eb9-bacb-4307-9003-5a223c16eed8)
- [Suven Pharmaceuticals Limited](https://www.keypedia.com/companies/suven-pharmaceuticals-limited/c01306bf-33dc-4f28-a424-11cda764a0d5)
- [Piramal Critical Care, Inc.](https://www.keypedia.com/companies/piramal-critical-care-inc/9cb01f72-bedf-48bc-acb6-d2d9933a3f0f)
- [Actavis Elizabeth LLC, A Company of Teva](https://www.keypedia.com/companies/actavis-elizabeth-llc-a-company-of-teva/c4a12fda-d6c3-4ad3-bac5-cc2b5695950e)
- [Roche Diagnostics GmbH](https://www.keypedia.com/companies/roche-diagnostics-gmbh/a23249df-90f8-49fa-8a07-267a69157488)

## Related Officers

- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)